20.73
전일 마감가:
$21.29
열려 있는:
$21.23
하루 거래량:
488.52K
Relative Volume:
0.73
시가총액:
$1.06B
수익:
$379.81M
순이익/손실:
$-21.35M
주가수익비율:
-52.57
EPS:
-0.3943
순현금흐름:
$35.44M
1주 성능:
+17.58%
1개월 성능:
+20.87%
6개월 성능:
+36.47%
1년 성능:
+22.37%
Caredx Inc Stock (CDNA) Company Profile
명칭
Caredx Inc
전화
415-287-2300
주소
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
CDNA
Caredx Inc
|
20.73 | 1.09B | 379.81M | -21.35M | 35.44M | -0.3943 |
|
TMO
Thermo Fisher Scientific Inc
|
524.57 | 195.48B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
194.54 | 138.36B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
569.01 | 46.31B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
122.09 | 34.18B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
335.23 | 32.95B | 3.17B | 642.63M | 516.49M | 10.77 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-06 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2025-08-26 | 개시 | William Blair | Mkt Perform |
| 2025-01-15 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | 개시 | Wells Fargo | Underweight |
| 2024-08-19 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-05-13 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2023-11-09 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2023-03-07 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2023-03-03 | 다운그레이드 | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | 개시 | Stephens | Overweight |
| 2021-07-20 | 재개 | BTIG Research | Buy |
| 2021-06-03 | 개시 | Goldman | Buy |
| 2021-02-26 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-08 | 재확인 | H.C. Wainwright | Buy |
| 2020-10-02 | 재확인 | H.C. Wainwright | Buy |
| 2020-08-05 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-26 | 개시 | BTIG Research | Buy |
| 2020-06-19 | 재확인 | H.C. Wainwright | Buy |
| 2019-10-01 | 재개 | Craig Hallum | Buy |
| 2019-05-09 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | 개시 | Jefferies | Buy |
| 2018-10-23 | 재개 | Raymond James | Strong Buy |
| 2018-09-18 | 재확인 | H.C. Wainwright | Neutral |
| 2017-11-27 | 개시 | H.C. Wainwright | Buy |
| 2016-06-14 | 재확인 | Mizuho | Buy |
| 2015-09-29 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | 개시 | Craig Hallum | Buy |
| 2015-03-18 | 재확인 | Mizuho | Buy |
모두보기
Caredx Inc 주식(CDNA)의 최신 뉴스
Keith Kennedy to Assume Dual Role at CareDx - Medical Product Outsourcing
CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for Heart and Lung Transplantation’s 46th Annual Meeting - The Joplin Globe
CareDx Launches AlloSeq Nano for High-Resolution Rapid HLA Typing - TradingView
Insider Sell: CareDx Inc (CDNA) President and CEO Hanna John Wal - GuruFocus
CareDx CEO John Hanna Jr. sells $217,155 in company stock - Investing.com
CareDx (CDNA) CEO sells 10,282 shares at $21.12 under Rule 10b5-1 plan - Stock Titan
CareDx (CDNA) to Sell Lab Products Division to EuroBio Scientifi - GuruFocus
CareDx (CDNA) Launches Innovative AlloSeq Nano Genotyping Soluti - GuruFocus
CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing - BioSpace
CareDx sharpens focus on core testing services - MSN
Assessing CareDx (CDNA) Valuation After Recent Share Price Momentum And Mixed Long Term Returns - Yahoo Finance
CareDx: Watch For Profit-Taking After Recent Positive Preliminary Q1 Results - Seeking Alpha
All You Need to Know About CareDx (CDNA) Rating Upgrade to Buy - Yahoo Finance
Analysts Conflicted on These Healthcare Names: CareDx (CDNA) and Pfizer (PFE) - The Globe and Mail
Are Medical Stocks Lagging CareCloud (CCLD) This Year? - Yahoo! Finance Canada
Sumitomo Mitsui Trust Group Inc. Trims Stake in CareDx, Inc. $CDNA - MarketBeat
CareDx, Inc. (CDNA) Stock Analysis: Exploring Growth Potential And Analyst Consensus - DirectorsTalk Interviews
CareDx Sharpens Focus On Core Testing Services - Sahm
Cathie Wood’s ARK sells CAREDX stock amid ongoing portfolio adjustments By Investing.com - Investing.com Australia
CareDx Inc (CDNA) Shares Surge 27.6% -- What GF Score of 80 Tells Investors - GuruFocus
Cathie Wood’s ARK sells CAREDX stock amid ongoing portfolio adjustments - Investing.com
Proposed CDNA common sales; John Hanna 10b5-1 trades (NASDAQ: CDNA) - Stock Titan
CareDx (CDNA) CEO has 62,049 shares withheld to cover RSU tax bill - Stock Titan
CareDx Up 28%, on Track for Largest Percent Increase Since May 2024 -- Data Talk - 富途牛牛
CareDx Sharpens Focus On Core Testing Services - Benzinga
CareDx (NASDAQ:CDNA) Reaches New 1-Year HighHere's Why - MarketBeat
CareDx Sells Lab Products Business to EuroBio Scientific for $170 Million, Reports 48% Growth in Testing Services Revenue - Minichart
Aehr Test Systems, CareDx, Okta And Other Big Stocks Moving Higher On Thursday - Benzinga
CareDx Divests Lab Products to Refocus on Core Growth - TipRanks
CDNA Reports 17% Increase in Q1 Testing Service Volume - GuruFocus
CareDx (NASDAQ: CDNA) divests Lab Products business in $170M Eurobio deal - Stock Titan
Eurobio scientific signs definitive agreement to acquire CareDx’s transplant Lab Product division - marketscreener.com
CareDx (CDNA) Soars After Divestiture Announcement and Strong Re - GuruFocus
CareDx (CDNA) Sells Lab Products Division for $170M - GuruFocus
CareDx to sell lab products unit for $170 million in cash - Investing.com India
BTIG Maintains CareDx (CDNA) Buy Recommendation - MSN
CareDx Divests Lab Products Business for $170M, Focuses on Precision Medicine Testing - National Today
(CDNA) Volatility Zones as Tactical Triggers - Stock Traders Daily
Caredx announces agreement to divest lab products business to Eurobio Scientific for $170 million and announces first quarter preliminary financial results - marketscreener.com
CareDx (CDNA) Sees 20% Surge Following Q1 Pre-Announcement - GuruFocus
CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial Results - Business Wire
CareDx and Omada Health Compared: Which Medical Stock Stands Out? - National Today
CareDx (CDNA) Q4 Earnings Miss Estimates - Eastern Progress
CareDx to Report First Quarter 2026 Financial Results on April 28, 2026 - BioSpace
How The CareDx (CDNA) Investment Story Is Shifting With New Targets And Policy Risks - Yahoo Finance
CareDx to sell lab products unit for $170 million in cash By Investing.com - Investing.com South Africa
Fenwick Represents CareDX in Divestiture of Lab Products Business to EuroBio Scientific - fenwick.com
Eurobio Scientific Société anonyme entered into a definitive agreement to acquire Lab Products Business of CareDx, Inc. for $170 million. - marketscreener.com
Press Release: CareDx to Report First Quarter 2026 Financial Results on April 28, 2026 - 富途牛牛
Aug PreEarnings: Whats the RSI of CareDx Inc stockMarket Trend Summary & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Book value per share of CareDx, Inc. – DUS:1K9 - TradingView — Track All Markets
Caredx Inc (CDNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):